Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases

Chronic liver disease (CLD) entails elevated risk of COVID-19 severity and mortality. The effectiveness of the booster dose of inactivated SARS-CoV-2 vaccine in stimulating antibody response in CLD patients is unclear. Therefore, we conducted a cross-sectional study involving 237 adult CLD patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yongmei, Lu, Jianhua, Zhan, Haoting, Yuan, Wenfang, Li, Xiaomeng, Kang, Haiyan, Li, Haolong, Chen, Yongliang, Cheng, Linlin, Sun, Xingli, Zheng, Haojie, Wang, Wei, Dai, Erhei, Li, Yongzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wuhan Institute of Virology, Chinese Academy of Sciences 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590695/
https://www.ncbi.nlm.nih.gov/pubmed/37487943
http://dx.doi.org/10.1016/j.virs.2023.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590695/
https://www.ncbi.nlm.nih.gov/pubmed/37487943
http://dx.doi.org/10.1016/j.virs.2023.07.005

Ejemplares similares